LoadingLoading ...

عربي

Birzeit-Palestine Pharmaceutical Company

   (BPC.PSE)
Also known as: BPC
Last Trade
3.00JOD
- 0.66%
 
 
 
 
 
 
 
 
 
 
 
 
 
Updated: Mar 14, 2007
 
 
 
Ownership Type
Company Type
Joint Stock
 
 
 
Zawya Industry Classifications (ZIC)
Sector Industry

Health Care

 
Principal Activities
Manufacture of generic drugs.
 
Date of Establishment Year
1974
 
No of Employees
200 (As of Dec 19, 2008)
 
Important/Recent Developments
In 1993, Birzeit Pharmaceutical Company merged with Palestine Medical Company under the name Birzeit-Palestine Pharmaceutical Company (BPC).
 
Branches
Palestine (3)    
 
Stock Market Listing
Exchange Symbol ID Stock Type Currency
Palestine SE  BPC BPC.PSE Ordinary JOD
 
 
Contact Details
Address:
P.O. Box 79
Ramallah  
West Bank
Palestinian Territories
 
Tel:
+970 2-298-7574
+970 2-298-7572
 
Fax:
+970 2-296-7206
 
Email:
info@bpc.ps
 
Website:
www.bpc.ps

 
 
 Major Shareholders  Section Updated: 29Nov11
Name   Type  Country  Holding 
Private investors  Private Palestinian Territories 89.00% 
Public   - 11.00% 
 
 
 Direct Investments and Related Entities 
Subsidiaries/Associates/Affiliates
Name  Country  Holding 
Easter Medical Company Palestinian Territories 100.00%
Palestine Press Company Palestinian Territories 100.00%
Medix Company Palestinian Territories 60.00%
Petrapharm Pharmaceutical Company Algeria 50.00%
Lotus Financial Investment Company Palestinian Territories 25.00%
Investments
Name  Country  Holding 
Belpharm Palestinian Territories 17.00%
Alrafah Microfinance Bank Palestinian Territories 4.17%
Al-Takaful Palestinian Insurance Company Palestinian Territories 0.03%
 
 
 Representatives
Auditors
Deloitte and Touche  
 
 
 Financial Results  31-Dec-09  31-Dec-10   Yr on Yr 
  JOD'000 JOD'000 change (%)
Total revenues  15,755 15,565 (1.21)
Net profit  3,532 4,071 15.27
Total assets 34,730 37,337 7.51
Paid-up capital 12,100 12,100 0.00
Shareholders' Equity 28,628 30,898 7.93
Shares outstanding 12,100 12,100 0.00
Market capitalization 45,859 44,044 (3.96)
» View Full Financials
 
 
 
 
 
 
 

People who viewed this also viewed